86 related articles for article (PubMed ID: 4011416)
1. [Immunologic capacity of tumour patients. I. Leukocyte migration inhibition with ppD in patients at different tumour stages].
Makidono R; Murakami J; Jingu K; Kitagawa S; Matsuura K; Makidono A
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Feb; 45(2):403-6. PubMed ID: 4011416
[No Abstract] [Full Text] [Related]
2. Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen.
Erard P
Clin Exp Immunol; 1974 Nov; 18(3):439-48. PubMed ID: 4619978
[TBL] [Abstract][Full Text] [Related]
3. Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen.
Sorensen TB; Kjaer M
Clin Exp Immunol; 1977 Oct; 30(1):168-72. PubMed ID: 606436
[TBL] [Abstract][Full Text] [Related]
4. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
Abai AM; Fekete B
Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
[TBL] [Abstract][Full Text] [Related]
5. [In vitro transfer of immunity against PPD with dialyzable extract of leukocytes from human colostrum].
Martínez-Cairo Cueto S; Alasio-Chávez C; Dávila Velázquez JR
Rev Alerg; 1992; 39(6):126-32. PubMed ID: 1492196
[TBL] [Abstract][Full Text] [Related]
6. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
7. [Restoration of antineoplastic reactivity of the leukocytes after preincubation].
Novikov DK; Shmakov AP
Biull Eksp Biol Med; 1979 Oct; 88(10):452-5. PubMed ID: 387109
[TBL] [Abstract][Full Text] [Related]
8. Comparison of direct and indirect migration inhibition tests and skin hypersensitivity to tuberculin (PPD).
Mrázová A; Vejbora O; Fixa B
J Hyg Epidemiol Microbiol Immunol; 1981; 25(1):42-51. PubMed ID: 7229355
[TBL] [Abstract][Full Text] [Related]
9. [Leukocyte migration inhibition reaction in trophoblastic tumor patients].
Kovaleva VL; Drozhzhina TA
Biull Eksp Biol Med; 1978 May; 85(5):580-2. PubMed ID: 207376
[TBL] [Abstract][Full Text] [Related]
10. Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation.
Repo H; Kostiala AA; Kosunen TU
Clin Exp Immunol; 1980 Feb; 39(2):442-8. PubMed ID: 6993072
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between the LIF test with PPD and the skin tuberculin reaction in experimental tuberculosis in guinea pigs].
Jovanović M; Simić MM
Glas Srp Akad Nauka Med; 1980; (32):229-35. PubMed ID: 7346336
[No Abstract] [Full Text] [Related]
12. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
[TBL] [Abstract][Full Text] [Related]
13. Correlation of PPD and BCG-induced leukocyte migration inhibition, delayed cutaneous hypersensitivity, lymphocyte transformation in vitro and humoral antibodies to PPD in man.
Fleer A; van der Hart M; Blok-Schut BJ; Schellekens PT
Eur J Immunol; 1976 Mar; 6(3):163-7. PubMed ID: 791653
[TBL] [Abstract][Full Text] [Related]
14. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
Schmeisser G; Kademann J
Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
[TBL] [Abstract][Full Text] [Related]
15. [Determination of the tuberculin hypersensitivity by in vitro method of leukocyte migration inhibition from the capillary micro-hematocrit].
Bobinac-Georgievski A; Cvoriscec B; Palecek I; Sabioncello A; Dekaris D
Acta Med Iugosl; 1974; 28(2):105-21. PubMed ID: 4839749
[No Abstract] [Full Text] [Related]
16. Test of leukocyte migration inhibition. II. Comparative study of the techniques in capillary tubes and in agarose.
Stanciu L; Urcan S; Radu D; Itu I; Popescu S
Med Interne; 1984; 22(1):67-70. PubMed ID: 6710051
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer.
Nékám K; Kalmár L; Gergely P; Kelemen G; Fekete B; Láng I; Lévai J; Petrányi GY
Clin Exp Immunol; 1977 Mar; 27(3):416-20. PubMed ID: 324669
[TBL] [Abstract][Full Text] [Related]
18. Studies of migration inhibition tests in penicillin hypersensitivity.
Warrington RJ; Sauder PJ; Rutherford WJ
Clin Exp Immunol; 1979 Oct; 38(1):148-57. PubMed ID: 393437
[TBL] [Abstract][Full Text] [Related]
19. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
Hashimoto Y; Sekiguchi S
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
[TBL] [Abstract][Full Text] [Related]
20. [Immunological status of patients with solid neoplasms].
Citterio F; Luciani G; Pozzetto U; Castagneto M
Minerva Chir; 1980 May; 35(10):717-22. PubMed ID: 6969868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
